Craig-Hallum initiates coverage on Harrow (NASDAQ:HROW) with a Buy rating and announces Price Target of $24.

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a y...

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

Harrow Health (NASDAQ:HROW) reported quarterly Adj losses of $(0.20) per share which missed the analyst consensus estimate of $...